Evidence map›Paper›PMID 31863798›Full record

ArticleExperimental hematology2020

CD34 and EPCR coordinately enrich functional murine hematopoietic stem cells under normal and inflammatory conditions.

Jennifer L Rabe, Giovanny Hernandez, James S Chavez, Taylor S Mills, Claus Nerlov, Eric M Pietras

Open access · greenAbstract read
In one paragraph

Article in Experimental hematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jennifer L RabeDivision of Hematology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Giovanny HernandezDivision of Hematology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
James S ChavezDivision of Hematology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Taylor S MillsDivision of Hematology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Claus NerlovMRC Molecular Hematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
Eric M PietrasDivision of Hematology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA; Department of Immunology & Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Electronic address: eric.pietras@CUAnschutz.edu.
University of Colorado Anschutz Medical Campus · USUniversity of Oxford · GB

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Impact of IL-1 signaling on hematopoietic stem cell function and emergence of clonal hematopoiesis.R01DK119394 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI PIETRAS, ERIC M · 2019 to 2023
$2.0M
Determining how aging-associated changes in the microenvironment contribute to leukemogenesisR01AG067584 · NIA · UNIVERSITY OF COLORADO DENVER · PI DEGREGORI, JAMES V · 2019 to 2022
$1.7M
Pro-inflammatory cytokines in hematopoietic stem cell functionK01DK098315 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI PIETRAS, ERIC M · 2014 to 2018
$691k
Role of RNA splicing factor U2AF1 in regulating hematopoietic stem cell inflammation responses.F31HL138754 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI RABE, JENNIFER L · 2017 to 2018
$60k
Medical Research Council G0701761Medical Research Council G0900892Medical Research Council MC_UU_00016/7Medical Research Council MC_UU_12009/7NCI NIH HHS P30 CA046934NHLBI NIH HHS F31 HL138754NIA NIH HHS R01 AG067584NIDDK NIH HHS K01 DK098315NIDDK NIH HHS R01 DK119394
6 · The paper itself

Abstract

Hematopoiesis is dynamically regulated to maintain blood system function under nonhomeostatic conditions such as inflammation and injury. However, common surface marker and hematopoietic stem cell (HSC) reporter systems used for prospective enrichment of HSCs have been less rigorously tested in these contexts. Here, we use two surface markers, EPCR/CD201 and CD34, to re-analyze dynamic changes in the HSC-enriched phenotypic SLAM compartment in a mouse model of chronic interleukin (IL)-1 exposure. EPCR and CD34 coordinately identify four functionally and molecularly distinct compartments within the SLAM fraction, including an EPCR

Indexed as

Cell ProliferationHematopoiesisStress, PhysiologicalAnimalsAntigens, CD34Endothelial Protein C ReceptorHematopoietic Stem CellsInflammationInterleukin-1MiceMice, TransgenicAntigens, CD34Endothelial Protein C ReceptorInterleukin-1Procr protein, mouse

Identifiers

PMID31863798
PMCPMC6938677
OpenAlexW2995196097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.